Publications by authors named "Audra F Bryan"

Article Synopsis
  • * Recent research highlights tau acetylation as a significant post-translational modification that influences both normal tau activity and its potentially harmful aggregation in tauopathies, particularly in specific brain regions affected by Alzheimer's.
  • * The study involved creating precise monoclonal antibodies that target acetylated tau and successfully validating their use in neurons, providing valuable tools for understanding tau behavior and possibly advancing diagnostics or treatments for tau-related diseases.
View Article and Find Full Text PDF

Background: Cohesin is an important structural regulator of the genome, regulating both three-dimensional genome organization and gene expression. The core cohesin trimer interacts with various HEAT repeat accessory subunits, yielding cohesin complexes of distinct compositions and potentially distinct functions. The roles of the two mutually exclusive HEAT repeat subunits PDS5A and PDS5B are not well understood.

View Article and Find Full Text PDF

Background: The cohesin complex is essential for proper chromosome structure and gene expression. Defects in cohesin subunits and regulators cause changes in cohesin complex dynamics and thereby alter three-dimensional genome organization. However, the molecular mechanisms that drive cohesin localization and function remain poorly understood.

View Article and Find Full Text PDF

Background: Sudden unexpected infant death (SUID) occurs unpredictably and remains unexplained after scene investigation and autopsy. Approximately 1 in 7 cases of SUID can be related to a cardiac cause, and developmental regulation of cardiac ion channel genes may contribute to SUID.

Objective: The goal of this study was to investigate the developmental changes in the spliceoforms of SCN5A and KCNQ1, 2 genes implicated in SUID.

View Article and Find Full Text PDF

WDR5 is a highly-conserved nuclear protein that performs multiple scaffolding functions in the context of chromatin. WDR5 is also a promising target for pharmacological inhibition in cancer, with small molecule inhibitors of an arginine-binding pocket of WDR5 (the 'WIN' site) showing efficacy against a range of cancer cell lines in vitro. Efforts to understand WDR5, or establish the mechanism of action of WIN site inhibitors, however, are stymied by its many functions in the nucleus, and a lack of knowledge of the conserved gene networks-if any-that are under its control.

View Article and Find Full Text PDF